DK0621777T3 - Pellets containing active substance and with a matrix of hydrophilic macromolecules, and process for their preparation - Google Patents

Pellets containing active substance and with a matrix of hydrophilic macromolecules, and process for their preparation

Info

Publication number
DK0621777T3
DK0621777T3 DK93902034.3T DK93902034T DK0621777T3 DK 0621777 T3 DK0621777 T3 DK 0621777T3 DK 93902034 T DK93902034 T DK 93902034T DK 0621777 T3 DK0621777 T3 DK 0621777T3
Authority
DK
Denmark
Prior art keywords
matrix
preparation
gelatin
active substance
containing active
Prior art date
Application number
DK93902034.3T
Other languages
Danish (da)
Inventor
Juergen Freidenreich
Juergen Werry
Ursula Schick
Jens-Christian Wunderlich
Original Assignee
Alfatec Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27435369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0621777(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE4201179A external-priority patent/DE4201179A1/en
Priority claimed from DE4201173A external-priority patent/DE4201173C2/en
Application filed by Alfatec Pharma Gmbh filed Critical Alfatec Pharma Gmbh
Application granted granted Critical
Publication of DK0621777T3 publication Critical patent/DK0621777T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A61K8/0225—Granulated powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

Solid body consists of at least one active agent (A) dispersed in a matrix consisting mainly of at least one hydrophilic macromolecular structure-forming agent (I) selected from collagen, gelatin, fractionated gelatin, collagen hydrolysate, gelatin derivs., vegetable proteins, vegetable protein hydrolysates and elastin hydrolysates. (I) is pref. a thermoreversible sol-gel former. Also claimed are mixts. of (A) and (I), where (I) may additionally be one or more of albumin, agar, gum arabic, pectin, etc.
DK93902034.3T 1992-01-17 1993-01-18 Pellets containing active substance and with a matrix of hydrophilic macromolecules, and process for their preparation DK0621777T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4201179A DE4201179A1 (en) 1992-01-17 1992-01-17 Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
DE4201173A DE4201173C2 (en) 1992-01-17 1992-01-17 Acute drugs in the form of pellets containing dihydropyridine derivatives and their preparation
US07/876,864 US5405616A (en) 1992-01-17 1992-04-30 Means for containing active substances, having a shell of hydrophilic macromolecules, active substances and process for preparation thereof
US07/876,877 US5384129A (en) 1992-01-17 1992-04-30 Pellets containing dihydropyridine derivatives process for the production thereof and use as rapid action dosage in heart and circulatory diseases

Publications (1)

Publication Number Publication Date
DK0621777T3 true DK0621777T3 (en) 1996-10-21

Family

ID=27435369

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95113398T DK0701815T3 (en) 1992-01-17 1993-01-18 Process for the preparation of active ingredient powders, granules or pellets with a basic structure of hydrophilic macar
DK93902034.3T DK0621777T3 (en) 1992-01-17 1993-01-18 Pellets containing active substance and with a matrix of hydrophilic macromolecules, and process for their preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK95113398T DK0701815T3 (en) 1992-01-17 1993-01-18 Process for the preparation of active ingredient powders, granules or pellets with a basic structure of hydrophilic macar

Country Status (10)

Country Link
EP (2) EP0621777B1 (en)
JP (1) JPH07502736A (en)
AT (2) ATE181666T1 (en)
AU (1) AU679906B2 (en)
CA (1) CA2128244C (en)
DE (2) DE59309678D1 (en)
DK (2) DK0701815T3 (en)
ES (2) ES2092808T3 (en)
GR (2) GR3021223T3 (en)
WO (1) WO1993013757A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714575B1 (en) * 1994-01-03 1996-02-02 Rhone Poulenc Nutrition Animal New granules containing living organisms for animal feed.
SE9704401D0 (en) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
DE50105469D1 (en) * 2001-03-22 2005-04-07 Cognis Iberia Sl Microcapsules (VII)
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
FR2843301B1 (en) * 2002-08-09 2004-10-22 Centre Nat Rech Scient GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS
FR2843302B1 (en) 2002-08-09 2004-10-22 Centre Nat Rech Scient GALENIC FORM FOR COLLECTIVE DELIVERY OF ACTIVE PRINCIPLES
AU2003276011A1 (en) * 2002-10-16 2004-05-04 Dr. Suwelack Skin And Health Care Ag Use of molded bodies for external application
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
WO2006014673A2 (en) 2004-07-19 2006-02-09 Nobex Corporation Insulin-oligomer conjugates, formulations and uses thereof
FR2887455B1 (en) * 2005-06-28 2007-08-10 Sanofi Aventis Sa FORMULATION WITH PROLONGED RELEASE OF ACTIVE MEDICINAL PRINCIPLES
PL2061427T3 (en) * 2006-09-15 2011-12-30 Echo Pharmaceuticals Bv Granulate containing a pharmaceutically active substance and an emulsifier and method for its manufacture
EP2063861B1 (en) 2006-09-15 2015-02-25 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
CN101904813A (en) 2009-04-22 2010-12-08 苏维拉克皮肤及健康护理公司 Freeze-dried coated mechanograph
ES2786506T3 (en) * 2012-08-01 2020-10-13 Zahra Tavakoli Flowable frozen compositions comprising a therapeutic agent
ITMI20122145A1 (en) * 2012-12-14 2014-06-15 Velleja Res Srl COMPOSITIONS FOR ORAL USE HYDRO-LAYERED CONTAINERS OF COLLAGEN, ELASTIN AND VITAMIN C FAVOR THE EXTRA-CELLULAR MATRIX DEPOSITION
LU102656B1 (en) 2021-03-11 2022-09-12 Prosecur Gmbh Liquid food supplement for immune stimulation, process for its production and use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1248863B (en) * 1959-01-30
GB887901A (en) * 1960-04-13 1900-01-01
IE53696B1 (en) * 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
US4642903A (en) * 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
FR2634121B1 (en) * 1988-07-13 1992-05-07 Imedex PROCESS FOR THE PREPARATION OF COLLAGEN MICROPARTICLES AND PRODUCTS OBTAINED
JPH02135052A (en) * 1988-11-17 1990-05-23 Taiyo Kagaku Co Ltd Preparation of granular food
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
FR2650502B1 (en) * 1989-08-07 1994-05-27 Delagrange Laboratoires NEW ORAL GALENIC FORM IMPROVING BIOAVAILABILITY
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
ATE156350T1 (en) 1992-01-17 1997-08-15 Alfatec Pharma Gmbh PELLETS CONTAINING PEPTIDE MEDICINAL SUBSTANCES AND THEIR PRODUCTION AND USE
DE59301262D1 (en) 1992-01-17 1996-02-08 Alfatec Pharma Gmbh METHOD FOR PRODUCING SOFT GEL CAPSULES BY A DROP METHOD
ES2102637T3 (en) 1992-01-17 1997-08-01 Alfatec Pharma Gmbh CRYOGRANULATED MOLDED BODIES CONTAINING AN EXTRACT OF ACTIVE VEGETABLE SUBSTANCES AND THEIR PHARMACEUTICAL OR COSMETIC USE.
DE4221880A1 (en) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Solid and liquid solutions of poorly water-soluble drugs

Also Published As

Publication number Publication date
CA2128244C (en) 1998-09-22
EP0621777B1 (en) 1996-09-11
EP0701815B1 (en) 1999-06-30
DE59303759C5 (en) 2009-04-09
DK0701815T3 (en) 2000-02-07
GR3021223T3 (en) 1997-01-31
ATE181666T1 (en) 1999-07-15
AU679906B2 (en) 1997-07-17
CA2128244A1 (en) 1993-07-22
EP0621777A1 (en) 1994-11-02
WO1993013757A1 (en) 1993-07-22
AU3343293A (en) 1993-08-03
JPH07502736A (en) 1995-03-23
DE59309678D1 (en) 1999-08-05
GR3030675T3 (en) 1999-11-30
DE59303759D1 (en) 1996-10-17
ES2133633T3 (en) 1999-09-16
ES2092808T3 (en) 1996-12-01
EP0701815A1 (en) 1996-03-20
ATE142484T1 (en) 1996-09-15

Similar Documents

Publication Publication Date Title
DK0621777T3 (en) Pellets containing active substance and with a matrix of hydrophilic macromolecules, and process for their preparation
ATE167486T1 (en) OSTEOGENIC DEVICES
DE68907707T2 (en) Enzyme stabilization.
WO1989009787A3 (en) Osteogenic devices
DE3781263D1 (en) PEPTIDE DERIVATIVES AND THEIR USE IN THERAPY.
NO954188D0 (en) Modified-protein and peptide - pharmaceuticals
DE69034091D1 (en) Production of hemoglobin and analogues thereof in non-erythrocyte cells
DE68917061T2 (en) O-glycosylated IGF-1.
ATE130872T1 (en) ANCROD SIMILAR PROTEINS, THEIR PRODUCTION AND USE.